The contributions of interleukin-17 (IL-17) to cancer remain unclear and somewhat controversial. We took a genetic approach to explore its role in prostate cancers by interbreeding IL-17 receptor C (IL-17RC) deficient mice with mice that are conditionally mutant for PTEN, one established preclinical model for prostate cancer. Mice that were IL-17RC deficient (IL-17RC-) displayed prostates that were smaller than mice that maintained IL-17RC expression (IL-17RC+). Additionally, IL-17RC-mice developed a reduced number of invasive prostate adenocarcinomas with lower rates of cellular proliferation and higher apoptosis, compared to IL-17RC+ mice. Moreover, the fibromuscular stroma surrounding prostatic glands was relatively thicker in IL-17RC-mice and was associated with decreased Mmp7 expression and increased Timp1,2,4 expression, whereas administration of recombinant mouse IL-17 induced prostatic expression of Mmp7. Taken together, our results suggested that IL-17 promotes the formation and growth of prostate adenocarcinoma, and that an IL-17-MMP7 signaling axis is required for the transition of prostatic intraepithelial neoplasia (PIN) to frank adenocarcinoma.
Introduction
Interleukin-17 (IL-17 or IL-17A) is the founder member of the IL-17 cytokine family, which shares 50% homology with IL-17F. IL-17 cytokines are produced by T H 17 cells, Ȗį T cells, and other immune cells. IL-17A and IL-17F form homodimers and heterodimers as functional ligands (1, 2). IL-17 cytokines bind to two receptors, IL-17RA and IL-17RC (3). IL-17RC forms a receptor heterodimer with IL-17RA (4, 5) . The receptor heterodimer is preferred by IL-17 ligands (6), thus, either IL-17RA knockout (KO) or IL-17RC KO completely abolishes IL-17 signaling (7, 8) . IL-17A and IL-17F are key proinflammatory cytokines involved in many inflammatory and autoimmune diseases (9) .
Almost all surgical prostate specimens contain inflammation (10) . Chronic inflammation invokes proliferative inflammatory atrophy (PIA) of prostate -a potential precursor lesion to prostatic intraepithelial neoplasia (PIN) and carcinoma (11) . The cause of prostatic inflammation includes infection, urine reflux, diet, estrogen, and physical trauma (12) . A high-fat diet increases intraprostatic inflammation and plasma levels of IL-17 in mice (13) . IL-17A expression is increased in 58% of prostate cancer specimens (14) and both IL-17RA and IL-17RC receptors are expressed in prostate cancer (5, 14) . It has been reported that T H 17 cell number is increased in prostate cancer (15) . A higher percentage of T H 17 cells in blood is correlated to poorer outcome (16) . When a mouse prostate cancer cell line TRAMP-C2 was implanted in IL-17RA KO mice, the tumor growth rate was slower than those tumors implanted in wild-type (WT) mice (17) . Taken together, the current knowledge links IL-17 to prostate cancer. However, the critical question of whether IL-17 has any role in prostate cancer has never been investigated in a mouse model of autochthonous prostate cancer. In the present study, we crossed Il17rc KO (Il17rc Author Manuscript Published OnlineFirst on March 28, 2012 ; DOI: 10.1158/0008-5472. Il17rc KO mice developed significantly smaller prostate tumors compared to Il17rc WT mice.
Our results suggest that IL-17 promotes formation and growth of prostate adenocarcinoma. Figure 1A . DNA was extracted from the tail biopsy for PCR genotyping as described (18) (19) (20) (see primer sequences in Supplementary Table 1) .
Materials and Methods

Mice
Histopathology. Mice were weighed at 4, 6, 9, 12, and 30 weeks of age. The genitourinary (GU) bloc consisting of the prostate lobes, seminal vesicles, ampullary glands, bladder, proximal ductus deferens, and proximal urethra was excised en bloc (21) . The GU blocs were photographed, weighed with an empty bladder, and fixed as described (21) . Fifty-six consecutive 5-μm sections of each prostate were cut and eight sections (from every 7 th section) were H&E stained for histopathologic assessment in a blinded fashion according to the Bar Harbor Instruments Inc., Melville, NY) was used to measure the thicknesses at six different points of the stroma layer around each gland; and the average of the six measurements represented the thickness of fibromuscular stroma of the gland. The number of inflammatory cells in the connective tissue space between the prostatic glands was counted in five high-power fields (x 400 magnification) per lobe; the average number of inflammatory cells per high-power field in 7 to 9 mouse prostates per genotype was compared.
Immunohistochemical and TUNEL staining. Immunohistochemical staining (IHC) and double immunofluorescent staining were performed as described (18, 22) . The antibodies used were: The male pups were genotyped at 3 weeks of age ( Fig. 1B-D and Il17rc -/-prostates expressed similar levels of IL-17RA (Fig. 2B ). Similar levels of C-C motif ligand 2 (Ccl2) and C-X-C motif ligand 1 (Cxcl1) mRNA expression were induced by rmIL-17
The GU-bloc weight is proportional to the prostate weight, thus it has often been used to represent the prostate tumor burden (24, 25) . Representative GU blocs of mice at 9, 12, and 30
weeks of age are presented in Figure 2D , showing that the GU blocs of 
;Pten L/L ;Cre + mice were named as IL-17RC-(or RC-in abbreviation). As shown in Figure 2E , there were no significant differences in the GU-bloc weights between IL-17RC+ and IL-17RC-mice at 4, 6, and 9 weeks of age (P > 0.05). However, the GU-bloc weight of IL-17RC+ mice was 14% and 47% heavier than that of IL-17RC-mice at 12 and 30 weeks of age, respectively (P = 0.005 and P = 0.004, respectively, using Student's t test). We did not find any significant differences in body weights between the two groups. We normalized the GU-bloc weight of each mouse by their corresponding body weight and found that the differences were still the same between the two groups ( Fig. 2F ).
In addition, we assessed the GU-bloc weights using a two-factor ANOVA and found that there was a significant age and genotype interaction (P = 0.0012). Using Tukey-Kramer adjustment for multiple comparisons, there were no significant differences in the GU-bloc weights through the first 12 weeks (P values varied from 0.2517 to 0.9635). However, the trajectories of the GU-bloc weights diverged soon after week 12 (see Fig. 2E ) and there were highly significant differences at 30 weeks (P < 0.0001).
IL-17RC knockout did not affect formation of PIN, but decreased formation of invasive adenocarcinoma
It was reported that Pten L/L ;Cre + mice (with Il17rc +/+ genotype) developed epithelial hyperplasia at 4 weeks, PIN at 6 weeks, and invasive adenocarcinoma at 9 weeks of age with 100%
penetrance (18) . We found epithelial hyperplasia in all of the IL-17RC+ and IL-17RC-mouse prostates at 4 weeks ( Fig. 3A-C) . At 6 weeks, mouse PIN was observed in all of the IL-17RC+
and IL-17RC-mouse prostates and the PIN-involved gland was bounded by an intact layer of fibromuscular stroma (Fig. 3D-F) . At 9 weeks, IL-17RC+ prostates developed invasive adenocarcinoma ( Fig. 3G-H presented as invasive adenocarcinoma in IL-17RC+ mice (Fig. 3M-N) . In contrast, only 70% of prostate lobes showed invasive adenocarcinoma (Fig. 3O ) in IL-17RC-mice, with the remaining 30% still presented as PIN. Invasion of the basement membrane and fibromuscular layer was confirmed by Į smooth muscle actin staining (Fig. 3P) . The percentages of PIN and invasive adenocarcinomas were significantly different between IL-17RC+ and IL-17RC-mice at 9, 12, and 30 weeks (P < 0.001, P < 0.001, and P < 0.005, respectively) ( Fig. 3Q ; see data from individual prostatic lobes in Supplementary Figure 1) .
IL-17RC knockout decreased cellular proliferation and increased apoptosis
To understand why IL-17RC+ mice developed bigger prostate tumors than IL-17RC-mice at 12 and 30 weeks, we assessed cellular proliferation and apoptosis by performing Ki-67 staining and TUNEL assays on each prostate lobe. We found that there were significantly more Ki-67-positive epithelial cells in IL-17RC+ prostates than in IL-17RC-prostates (Fig. 4A-B ). In addition, there were significantly fewer apoptotic cells in IL-17RC+ prostates than in IL-17RC-prostates ( Fig. 4C-D) .
IL-17RC knockout increased the thickness of fibromuscular stroma
To understand why IL-17RC-mice developed fewer invasive adenocarcinomas than IL-17RC+ mice at 9 to 30 weeks, we examined the histopathological features of the mouse prostates.
Normal mouse prostate has a thin rim of fibromuscular stroma surrounding individual glands (Fig. 5A) (21) . The layer of fibromuscular stroma in IL-17RC-mice was dramatically thicker compared to age-matched normal prostates (Fig. 5B) . In contrast, the layer of fibromuscular stroma in IL-17RC+ mice (Fig. 5C ) was obviously thinner than that of IL-17RC-mice. Laminin staining confirmed what were observed with H&E staining (Fig. 5D-I sections in Supplementary Figure 2A-B) . The thickness of the fibromuscular stroma was measured using computer software (Fig. 5J) . As shown in Figure 5K , the thickness of the fibromuscular stroma was significantly thicker in IL-17RC-mice compared to either IL-17RC+ mice or normal mice at 9, 12, and 30 weeks (P < 0.001 for all comparisons; see data from individual prostatic lobes in Supplementary Figure 3A) .
IL-17RC knockout decreased Mmp7 expression
To investigate the molecular mechanisms underlying the different thicknesses of fibromuscular stroma, we screened seven Mmps and four Timps that are associated with prostate cancer (26) .
We found that, in the mouse prostates, the most abundant Mmp mRNA was Mmp7, the level of which was over 15,000 times higher than the levels of Mmp2, 8, 9, 10, and 13. The second most abundant Mmp mRNA was Mmp3, the level of which was approximately 3% of Mmp7 (Fig. 6A ). More importantly, Mmp7 mRNA level was significantly higher in IL-17RC+ mice than in IL-17RC-mice at 9 weeks (P < 0.01) (Fig. 6A) . Mmp7 mRNA expression increased at 12 and 30 weeks in both IL-17RC+ and IL-17RC-mice, but the levels of Mmp7 mRNA were still significantly higher in IL-17RC+ mice than in IL-17RC-mice (P < 0.01) (Fig. 6B ). In addition, we found that the mRNA levels of Timp1, 2, and 4 were significantly higher in IL-17RC-mice than in IL-17RC+ mice (P < 0.05 or P < 0.01) (Fig. 6A) . Using IHC, we found that MMP7 protein was not detectable in either IL-17RC+ (Fig. 6C) or IL-17RC- (Fig. 6D ) mouse prostatic lateral lobes at 4 weeks. At 6 weeks, only a few cells of the PIN lesions in IL-17RC+ mice stained positive for MMP7 (Fig. 6E) , whereas the PIN cells in IL-17RC-mice stained negative (Fig. 6F) . At 9 weeks, almost all neoplastic epithelial cells including the cells at the front edge of tumor invasion stained positive for MMP7 in IL-17RC+ mice (Fig. 6G) . In contrast, only a few cells of the PIN lesions in IL-17RC-mice stained positive (Fig. 6H) . At 12 and 30 weeks, the invasive adenocarcinoma cells in IL-17RC+ mice stained strongly positive for MMP7 (Fig. 6I and 6J), whereas only a few neoplastic epithelial cells in IL-17RC-mice stained positive ( Fig.   6K and 6L ). We did not see positive MMP7 staining in the stromal cells (Fig. 6C to 6L) . Similar results were obtained in other prostatic lobes (see data of dorsal lobes in Supplementary Figure   3B ). To confirm the differences of MMP7 protein expression, we performed Western blot analysis using protein lysates from 9-week-old mouse prostates. We found that indeed MMP7 protein level was higher in IL-17RC+ mice than in IL-17RC-mice and was not detectable in normal mouse prostates at 9 weeks of age (Fig. 6M) (Fig. 6N) . Furthermore, we found that rmIL-17 treatment increased MMP7 protein expression in Il17rc +/+ but not in Il17rc -/-mouse prostate tissues (Fig. 6O ).
IL-17RC knockout decreased inflammatory cell infiltration in the prostate
We found that IL-17RC+ mouse prostates had many inflammatory cells in the connective tissue space between the prostatic glands, particularly at 30 weeks of age; however, the number of inflammatory cells was significantly reduced in IL-17RC-mouse prostates ( Fig. 7A-E ). The inflammatory cell population was mainly composed of macrophages and lymphocytes, with few neutrophils (Fig. 7C-D) . 
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The role of IL-17 in cancer growth has been debated for over a decade (27, 28) . One opinion is that IL-17 is pro-tumorigenic (29, 30) , whereas another notion is that IL-17 is anti-tumorigenic (31, 32) . The discrepancies may be caused by many factors, such as using nude mice, overexpression of IL-17, and grafting of different tumor types. It must be pointed out that IL-17 exerts its proinflammatory effects by targeting immune cells and body tissues with cytokines, chemokines, and MMPs (9) . Therefore, an intact immune system is critical for the proper functioning of IL-17 and the findings from the allograft studies in immunocompetent mice are presumably more convincing than the ones from nude mice. However, two groups of investigators have found opposite functions of IL-17 in tumor growth using the same IL-17 KO mouse strain but different murine tumor allografts (33, 34) . One interpretation for the conflicting results is that IL-17's action may be tumor-specific. Yet, the differences in strengths of the antigenicity of tumor allografts may also cause different responses from the animal hosts, as IL-17 promotes organ allograft rejection (35) . Taken together, in order to properly evaluate IL-17's role in cancer, it would be better to use immunocompetent animal models of autochthonous cancer, rather than tumor xenograft or allograft models.
In this study, we used the Pten conditional KO mouse model of autochthonous prostate adenocarcinoma (18, 36) , which, among the currently available animal models of prostate cancer, most closely imitates formation and growth of the human prostate adenocarcinomas (37) . Two significant phenotypical differences were found between the IL-17RC+ and IL-17RC-groups. The first is that the GU-bloc weight was 47% heavier in IL-17RC+ mice than in IL-17RC-mice at 30 weeks. The difference was statistically significant in both Student's t test and Tukey-Kramer method. At 12 weeks, the GU-bloc weight was 14% heavier in IL-17RC+ mice than in IL-17RC-mice, which was statistically significant in Student's t test (P = 0.005) but 
PIN-involved glands and invade into the surrounding stroma (21) . Thus, degradation of the basement membrane and invasion of the stroma are critical steps in PIN-to-adenocarcinoma transition. Interestingly, we found that the layer of fibromuscular stroma surrounding the glands was significantly thicker in IL-17RC-mice than in IL-17RC+ mice, which suggests that there is either an increase of stroma synthesis or a decrease in stroma degradation, or both in IL-17RC-mice. Since we did not find any differences in cellular proliferation or apoptosis of the stromal cells between IL-17RC+ and IL-17RC-mice (Fig. 4A and 4C) , we focused on stroma degradation. Matrix-degrading enzymes are critical for the PIN-to-adenocarcinoma transition as they are needed in dissolution of basement membrane components. These enzymes include MMPs, aspartyl proteases (e.g., cathepsin D), and serine proteases (e.,g, urokinase-like plasminogen activator and prostate-specific antigen). MMP2, 3, 7, and 9 as well as their inhibitors TIMP1 and TIMP2 have been associated with malignant progression of prostate cancer (26) . We found that Mmp7 mRNA was the most abundant Mmp in the mouse prostates. MMP7 protein levels were not readily detectable at 4 and 6 weeks, but dramatically increased at 9 weeks in IL-17RC+ mouse prostates. The timing of MMP7 protein expression matches the critical period of PIN-to-adenocarcinoma transition between 6 to 9 weeks. More importantly, Mmp7 mRNA and protein expression was significantly reduced in IL-17RC-mice compared to IL-17RC+ mice at 9, 12, and 30 weeks, which paralleled the increase in stroma thickness and the decrease in forming invasive adenocarcinomas in IL-17RC-mice. Furthermore, we found that rmIL-17 treatment induced Mmp7 mRNA and protein expression in the ex vivo cultured IL-17RC+ prostates but not in IL-17RC-prostates, which suggests that Mmp7 is a new downstream target gene of IL-17 signaling. It is known that IL-17 induces expression of MMP1, 2, 3, 9, and 13 in synoviocytes and chondrocytes (9) . Thus, we conclude that Il17rc KO leads to decreased Thus, we speculate that a reduction in inflammatory cell infiltration partially contributes to the observed tumor growth inhibition in IL-17RC-mice.
In summary, the present study provides evidence that IL-17 promotes formation and growth of prostate adenocarcinoma in a mouse model. In this model, Pten deletion is the driving force of a series of pathological changes (Fig. 7F) . However, IL-17 cytokines act through IL-17RA:IL-17RC heterodimer receptors to induce Mmp7 expression, which plays an important role in the PIN-to-adenocarcinoma transition (Fig. 7F) of pancreatic ductal adenocarcinoma and metastasis (43) . This finding is consistent with our result that IL-17-induced Mmp7 expression did not affect PIN formation, but affected PIN-toadenocarcinoma transition. Similarly, Mmp7 is required for intestinal adenocarcinoma formation (44, 45) and development of early focal lesions in mammary tumorigenesis (46) . These findings including ours suggest that MMP7 may play a critical role in formation of a variety of adenocarcinomas. In addition, IL-17 signaling may increase cellular proliferation, inhibit apoptosis, and enhance inflammation, thus promoting tumor growth (Fig. 7F) . IL-17's protumorigenic role has also been demonstrated in several recent studies. Xiao et al (47) found that anti-IL-17 antibodies decreased inflammation and delayed papilloma formation in mouse skin, which was confirmed by a study using IL-17 KO mice (48) . Neutralization of IL-17 in mice also inhibited colon cancer formation (49) , which was confirmed independently by another study using IL-17 KO mice (50) . Taken together, these recent findings support the opinion that IL-17 promotes tumor formation and growth, at least in skin cancer, intestinal adenocarcinoma, and prostate adenocarcinoma. 
